fda approval tirzepatide Approves Diabetes Drug for Chronic Weight Management FDA-Approved Tirzepatide: A Game Changer

Accessed 6 Mar 2024

GP Lead BSc (Hons), MBBS, MRCGP, PGDip (SEM), DFSEM Dr

Additional UK SmPC warnings include diabetic retinopathy complications (particularly with rapid HbA1c improvement), gallbladder disease, and risk of dehydration leading to acute kidney injury

55 ENDOSCOPIC ABLATION Circumferential or focal RFA is performed 56 and then repeated after 34 months if there is residual intestinal metaplasia

[DOI] [PubMed] [Google Scholar] 12.Selvarajah V., Robertson D., Hansen L., et al

Versus semaglutide, tirzepatide 10 and 15 mg were associated with numerically higher odds of participants achieving 5%, 10% and 15% weight reduction, and statistically higher odds of participants achieving 20% weight reduction